What one share of Collegium Pharmaceutical holds
Our mission is to build a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. We have developed, licensed, and acquired a portfolio of meaningfully differentiated products for use in the treatment of attention deficit hyperactivity disorder (“ADHD”) and moderate to severe pain.
Collegium Pharmaceutical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $22.31 |
|---|---|
| Profit | $1.44 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | $9.06 |
| Cash and investments | $3.98 |
| Debt | $7.35 |
| Book value | $9.60 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$1.48 | $0.02 | −$1.19 | — | $4.10 |
| 2016 | $0.07 | −$3.88 | $0.02 | −$3.11 | — | $4.59 |
| 2017 | $0.94 | −$2.47 | $0.03 | −$2.25 | — | $3.18 |
| 2018 | $8.51 | −$1.19 | $0.17 | $4.97 | — | $2.75 |
| 2019 | $8.87 | −$0.68 | $0.19 | $0.64 | — | $2.60 |
| 2020 | $8.82 | $0.76 | $0.16 | $2.51 | — | $5.37 |
| 2021 | $6.75 | $1.86 | $0.05 | $2.48 | — | $6.03 |
| 2022 | $13.71 | −$0.74 | $0.05 | $3.62 | — | $5.76 |
| 2023 | $13.56 | $1.29 | $0.01 | $6.56 | — | $6.13 |
| 2024 | $15.62 | $1.86 | $0.04 | $5.03 | — | $7.28 |
| 2025 | $19.66 | $1.73 | $0.04 | $8.25 | — | $9.51 |
Common questions about Collegium Pharmaceutical
How much does one share of Collegium Pharmaceutical earn?
Over the last 12 months, each share of Collegium Pharmaceutical earned $1.44 of profit on $22.31 of sales, keeping about 6¢ of every $1 (profit margin).
Does Collegium Pharmaceutical pay a dividend?
Collegium Pharmaceutical didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Collegium Pharmaceutical’s book value per share?
Collegium Pharmaceutical’s book value is $9.60 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Collegium Pharmaceutical have?
Each share of Collegium Pharmaceutical has $3.98 of cash and investments and $7.35 of debt, as of June 30, 2026.
What is Collegium Pharmaceutical’s free cash flow per share?
$9.06 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Collegium Pharmaceutical bought back shares?
Collegium Pharmaceutical’s share count rose about 116% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.